Ignite Creation Date:
2025-12-24 @ 5:03 PM
Ignite Modification Date:
2025-12-27 @ 6:52 AM
Study NCT ID:
NCT00694850
Status:
COMPLETED
Last Update Posted:
2025-07-28
First Post:
2008-06-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension (PH)
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-08-02
Start Date Type:
ACTUAL
Primary Completion Date:
2025-07-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-07-03
Completion Date Type:
ACTUAL
First Submit Date:
2008-06-09
First Submit QC Date:
None
Study First Post Date:
2008-06-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-25
Last Update Post Date:
2025-07-28
Last Update Post Date Type:
ACTUAL